Hernane, Christene L.
HRN: 13-73-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2023
METRONIDAZOLE 500MG (TAB)
05/14/2023
05/23/2023
PO
500 Mg
TID
Infectious Diarrhea Sec To Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes